Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder
- 1 June 2002
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 159 (6), 1018-1028
- https://doi.org/10.1176/appi.ajp.159.6.1018
Abstract
OBJECTIVE: Newer antipsychotic drugs have shown promise in ameliorating neurocognitive deficits in patients with schizophrenia, but few studies have compared newer antipsychotic drugs with both clo...Keywords
This publication has 27 references indexed in Scilit:
- Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or HaloperidolArchives of General Psychiatry, 2000
- The Role of Serotonin in Antipsychotic Drug ActionNeuropsychopharmacology, 1999
- Improvement of Cognitive Function in Schizophrenic Patients Receiving Clozapine or Zotepine: Results from a Double-Blind StudyPharmacopsychiatry, 1997
- Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophreniaSchizophrenia Research, 1995
- Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Effects of anticholinergic medication on memory in schizophreniaSchizophrenia Research, 1990
- Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.Journal of Abnormal Psychology, 1989
- Rapid and sensitive method for determination of haloperidol in human samples using nitrogen—phosphorus selective detectionJournal of Chromatography A, 1978
- The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophreniaJournal of Clinical Psychology, 1965